Ушбу иш иқтибос қилган ишлар

298 та иш

Иш: Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

Targeting the proliferation of glioblastoma cells and enhancement of doxorubicin and temozolomide cytotoxicity through inhibition of PFKFB4 and HMOX1 genes with siRNAs
Hamzeh J. Al‐Ameer, Malek Zihlif, Ahmed O. Maslat +13
Мақола202510 иқтибос
ABI
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott +26
Мақола20109 иқтибос
ABI
Polymeric Nanoparticles for Drug Delivery
Maximilian A. Beach, Umeka Nayanathara, Yanting Gao +4
Шарҳ мақола20247 иқтибос
ABI
Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade
Yoshiko Iwai, Masayoshi Ishida, Yoshimasa Tanaka +3
Мақола20025 иқтибос
ABI
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Robert D. Schreiber, Lloyd J. Old, Mark J. Smyth
Шарҳ мақола20115 иқтибос
ABI
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Dung T. Le, Jennifer N. Uram, Hao Wang +32
Мақола20155 иқтибос
ABI
Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade
Peng Li, Deepak Nijhawan, I. Imawati Budihardjo +4
Мақола19974 иқтибос
ABI
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo +13
Мақола20064 иқтибос
ABI
Exploration of the protein and pharmacological landscape of monkeypox virus treatment: from entry point to end point
Cena Aram, Maryam Barancheshmeh, Ali Alishvandi +6
Мақола20254 иқтибос
ABI
Pro-inflammatory programmed cell death
Brad T. Cookson, Molly A. Brennan
Бошқа20013 иқтибос
ABI
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk, Michalina Janiszewska, Kornélia Polyák
Шарҳ мақола20203 иқтибос
ABI
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Paul Baas +22
Мақола20153 иқтибос
ABI
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Jianjin Shi, Yue Zhao, Kun Wang +7
Мақола20153 иқтибос
ABI
Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling
Nobuhiko Kayagaki, Irma B. Stowe, Bettina L. Lee +22
Мақола20153 иқтибос
ABI
Inflammasomes: mechanism of assembly, regulation and signalling
Petr Brož, Vishva M. Dixit
Шарҳ мақола20163 иқтибос
ABI
An endogenous caspase-11 ligand elicits interleukin-1 release from living dendritic cells
Ivan Zanoni, Yunhao Tan, Marco Di Gioia +8
Мақола20163 иқтибос
ABI
Breast cancer: pathogenesis and treatments
Xin Xiong, Lewei Zheng, Yu‐Qiang Ding +7
Шарҳ мақола20253 иқтибос
ABI
An update on the regulatory mechanisms of NLRP3 inflammasome activation
Seungwha Paik, Jin Kyung Kim, Prashanta Silwal +2
Шарҳ мақола20213 иқтибос
ABI
Enhancement of Antitumor Immunity by CTLA-4 Blockade
Dana R. Leach, Matthew F. Krummel, James P. Allison
Мақола19963 иқтибос
ABI
Gene regulation by non-Coding RNAs in infertility: a mechanistic review
AmirHossien Borji, Cena Aram, Fatemeh Ziyadloo +6
Мақола20253 иқтибос
ABI
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jérôme Galon, Daniela Bruni
Шарҳ мақола20192 иқтибос
ABI
Role of pyroptosis in inflammation and cancer
Wei Xiang, Feng Xie, Xiaoxue Zhou +7
Шарҳ мақола20222 иқтибос
ABI
Immunotherapy of targeting MDSCs in tumor microenvironment
Hongshu Sui, Shengyi Dongye, Xiaocui Liu +11
Шарҳ мақола20222 иқтибос
ABI
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal +33
Мақола20162 иқтибос
ABI
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine
Zahra Izadiyan, Misni Misran, Katayoon Kalantari +5
Шарҳ мақола20252 иқтибос
ABI